Patient Association: Lymphoma Association Flanders (Belgium): Difference between revisions
From Beacon
No edit summary |
m (Update categories.) |
||
| (5 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
Go back to [[Belgium]] page | Go back to [[Belgium]] page | ||
<span style="display:none">forpatients</span> <span style="display:none">belgiumcountry</span> | |||
'''Primary purpose:''' To support and advocate for lymphoma patients and their families while promoting awareness and improving the overall care and well-being of those affected by the disease. | '''Primary purpose:''' To support and advocate for lymphoma patients and their families while promoting awareness and improving the overall care and well-being of those affected by the disease. | ||
| Line 7: | Line 7: | ||
'''Access to information:''' [https://www.lymfklierkanker.be/nl/home Click here to access]. | '''Access to information:''' [https://www.lymfklierkanker.be/nl/home Click here to access]. | ||
<span style="display:none">isPatientAssociation</span> | |||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | |||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | |||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
<span style="display:none">Lymphatic</span> | |||
<span style="display:none">Lymphoid</span> | |||
<span style="display:none">Lymphoma</span> | |||
<span style="display:none">Hematologic</span> | |||
<span style="display:none">Hematopoietic</span> | |||
<span style="display:none">Myeloma</span> | |||
<span style="display:none">Plasma cell</span> | |||
Latest revision as of 12:06, 14 December 2025
Go back to Belgium page
Primary purpose: To support and advocate for lymphoma patients and their families while promoting awareness and improving the overall care and well-being of those affected by the disease.
Cancer areas of interest: C81-C96: Cancers of the blood and immune system. Click here to learn more.
Access to information: Click here to access.
